Error 404 - Not Found

Suggestions

Bextra Whistleblower Case Started Investigation of Pfizer

How Pfizer Hid a $2.3 Bill. Bextra Settlement in Plain Sight Jan 26, 2009 The company said the Bextra investigation had been “previously disclosed”: Fourth-quarter 2008 results were impacted by a $2.3 billion

Pfizer Takes $2.3 Billion Charge Linked to Bextra Probe - Health But those settlements didn't apply to the “ investigation by the Department of Justice of the marketing of the company's Cox-2 medicines, particularly Bextra

PharmaGossip: Pfizer - Bextra : DOJ press conference Sep 2, 2009 The U.S. Attorney's Office for the District of Massachusetts led the criminal investigation of Bextra . The investigation was conducted by

The United States Department of Justice - United States Attorney's Mar 30, 2009 HOLLOWAY also instructed her staff to market Bextra for use before, The case was investigated by the Federal Bureau of Investigation ,

Bextra Side Effects Pfizer Settlement Jan 29, 2009 with the Massachusetts US Attorney to “resolve previously disclosed investigations " regarding Bextra and "other open investigations ."

Bextra off-label whistleblower case -- Pfizer $2.3 billion settlement Sep 2, 2009 Bextra whistleblower case started investigation of Pfizer $1.8 billion of historic settlement covers civil and criminal fines for dangerous

Pfizer Reports Fourth-Quarter and Full-Year 2008 Results and 2009 Jan 26, 2009 offset by the aforementioned charge related to Bextra and other open investigations in fourth-quarter 2008, as well as the after-tax

Bextra News | Articles About the Bextra Recall and Lawsuit Pfizer reached an agreement with the U.S. Attorney in Massachusetts to "resolve previously disclosed investigations " regarding Bextra and "other open

Pfizer Agrees to $2.3 Billion Payment, Plea in Probe (Update1 Pfizer acquired Bextra through its purchase of Pharmacia Corp. in 2003. pay $2.3 billion to settle an investigation into illegal marketing of medicines.